GSK has been granted a patent for a modular production system designed to produce sterile containers. The system features interconnected modules, including a sterilization module with an irradiation source, which maintains higher internal pressure and facilitates the sterilization process for containers passing through. GlobalData’s report on GSK gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on GSK, Human telomerase RT biomarker was a key innovation area identified from patents. GSK's grant share as of June 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Modular system for sterilizing containers using pressurized fluid
The patent US12043436B2 outlines a comprehensive process for producing sterile containers for various materials. The process begins with the provision of at least one container to be sterilized and involves a modular production system that includes an infeed module, a sterilization module, and an outfeed module. Each module is designed with a housing that defines an entrance, exit, and internal cavity, creating a production tunnel for the containers. The system incorporates a transport mechanism that facilitates the movement of containers through the modules, while a pressurized fluid source maintains atmospheric pressure within the production tunnel. The sterilization module features an irradiation source that sterilizes the containers at a specified temperature, ensuring they are free from contaminants before being transported to the outfeed module.
Additionally, the process includes optional cooling and filling modules positioned between the sterilization and outfeed modules. The cooling module utilizes cold air to reduce the temperature of the sterilized containers, while the filling module is equipped with a mechanism to deliver materials, such as liquids or powders, into the cooled containers. The process culminates in a closure module that seals the filled containers, which can involve various sealing methods, including caps or crimping. The entire system is designed to ensure efficient transport and processing of containers, ultimately allowing for the offloading of sterilized, filled, and sealed containers from the outfeed module. This innovative approach enhances the production of sterile containers, particularly in pharmaceutical and medical applications.
To know more about GlobalData’s detailed insights on GSK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.